Is oxidative stress involved in vernal keratoconjunctivitis? Results from a pilot study in children.
Hydrogen peroxide
children
cyclosporine A
oxidative stress
vernal keratoconjunctivitis
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
11
09
2020
revised:
16
09
2020
accepted:
17
09
2020
entrez:
25
11
2020
pubmed:
26
11
2020
medline:
19
8
2021
Statut:
ppublish
Résumé
Vernal keratoconjunctivitis (VKC) is a rare chronic conjunctivitis characterized by a predominantly eosinophil-mediated inflammatory disorder that could develop critical complications such as blindness. Oxidative stress plays a pivotal role in the pathogenesis of several allergic diseases. The role of oxidative stress has been hypothesized in VKC, but no study explored this issue. Furthermore, cyclosporine A (CsA) exerts an anti-inflammatory and antioxidant action on the conjunctiva. This study aimed to assess the oxidative stress in VKC patients and controls and to study the effect of CsA on oxidative stress in these subjects. Thirty-six consecutive children, including 12 VKC (nine males, 75%; mean age 10.17; SD ± 2.48) patients without treatment, 12 VKC patients treated with CsA (nine males, 75%; mean age 9.08; SD ± 2.75), and 12 controls (CT) (seven males, 58%; mean age 8.58; SD ± 1.78), were recruited. A cross-sectional study was performed to compare H Compared with CT and VKC children treated with CsA, VKC untreated children had significantly higher values of hydrogen peroxide (H This study provides the first report attesting that patients with VKC have high oxidative stress; furthermore, it suggests that CsA could have an anti-inflammatory and antioxidant action that could be useful to prevent the poor VKC outcome.
Sections du résumé
BACKGROUND
Vernal keratoconjunctivitis (VKC) is a rare chronic conjunctivitis characterized by a predominantly eosinophil-mediated inflammatory disorder that could develop critical complications such as blindness. Oxidative stress plays a pivotal role in the pathogenesis of several allergic diseases. The role of oxidative stress has been hypothesized in VKC, but no study explored this issue. Furthermore, cyclosporine A (CsA) exerts an anti-inflammatory and antioxidant action on the conjunctiva. This study aimed to assess the oxidative stress in VKC patients and controls and to study the effect of CsA on oxidative stress in these subjects.
METHODS
Thirty-six consecutive children, including 12 VKC (nine males, 75%; mean age 10.17; SD ± 2.48) patients without treatment, 12 VKC patients treated with CsA (nine males, 75%; mean age 9.08; SD ± 2.75), and 12 controls (CT) (seven males, 58%; mean age 8.58; SD ± 1.78), were recruited. A cross-sectional study was performed to compare H
RESULTS
Compared with CT and VKC children treated with CsA, VKC untreated children had significantly higher values of hydrogen peroxide (H
CONCLUSION
This study provides the first report attesting that patients with VKC have high oxidative stress; furthermore, it suggests that CsA could have an anti-inflammatory and antioxidant action that could be useful to prevent the poor VKC outcome.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
52-56Informations de copyright
© 2020 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Zicari AM, Capata G, Nebbioso M, et al. Vernal Keratoconjunctivitis: an update focused on clinical grading system. Ital J Pediatr. 2019;45(1):64.
Zicari AM, Nebbioso M, Lollobrigida V, et al. Vernal keratoconjunctivitis: atopy and autoimmunity. Eur Rev Med Pharmacol Sci. 2013;17(10):1419-1423.
Zicari AM, Zicari A, Nebbioso M, et al. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis. Pediatr Allergy Immunol. 2014;25(1):57-63.
Dadaci Z, Oncel M, Oncel AN, et al. Oxidative stress parameters and serum magnesium levels in patients with seasonal allergic conjunctivitis. Cutan Ocul Toxicol. 2016;35(4):270-274.
Bacsi A, Dharajiya N, Choudhury BK, et al. Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J Allergy Clin Immunol. 2005;116(4):836-843.
Smith RE, Ozben T, Saso L. Modulation of oxidative stress: pharmaceutical and pharmacological aspects 2018. Oxid Med Cell Longev. 2019;2019:6380473.
Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757e72.
Wakamatsu TH, Dogru M, Ayako I. Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease. Mol Vis. 2010;16:2465-2475.
Ma M, Ma X, Cui J, et al. Cyclosporin A protected cardiomyocytes against oxidative stress injury by inhibition of NF-κB signaling pathway. Cardiovasc Eng Technol. 2019;10(2):329-343.
Leonardi A, Doan S, Amrane M, et al. A randomized controlled trial of cyclosporine a cationic emulsion in pediatric vernal keratoconjunctivitis: the VEKTIS study. Ophthalmology. 2019;126(5):671-681.